Related Experiment Video
Updated: Jun 27, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
CD48 as a novel target in asthma therapy
Ariel Munitz1, Ido Bachelet, Francesca Levi-Schaffer
1Department of Pharmacology & Experimental Therapeutics, The School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Recent Patents on Inflammation & Allergy Drug Discovery
|December 17, 2008
Summary
CD48, a critical immune effector molecule, plays roles in adhesion, activation, and cytokine regulation. Its potential as a therapeutic target for immune disorders like asthma and cancer is increasingly recognized.
Area of Science:
- Immunology
- Molecular Biology
- Therapeutic Development
Background:
- CD48 is a CD2-related surface molecule with diverse biological functions including cell adhesion, pathogen recognition, cellular activation, and cytokine regulation.
- Despite its known functions, CD48 has not been fully exploited as a therapeutic target for immune disorders such as hematopoietic tumors, autoimmunity, and allergic reactions.
Purpose of the Study:
- To review the known aspects of CD48 biology.
- To discuss recent advances in understanding CD48's role in human diseases.
- To explore the potential of CD48 as a future therapeutic target for allergic and other immune-related diseases.
Main Methods:
- Literature review of CD48 biology and function.
- Analysis of recent research on CD48 in human diseases, including asthma and eosinophil function.
- Review of patents and inventions related to CD48 therapeutics.
Main Results:
- CD48 is a key effector molecule in immune responses with implications in various biological processes.
- Emerging evidence highlights CD48's involvement in human diseases, particularly in asthma and eosinophil function.
- Several inventions and patents demonstrate the growing interest in targeting CD48 for therapeutic interventions.
Conclusions:
- CD48 is a versatile immune effector molecule with significant therapeutic potential.
- Further research into CD48's role in disease pathogenesis is warranted.
- Targeting CD48 offers a promising avenue for developing novel therapies for allergic and other immune-mediated disorders.
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: